{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:44:29Z","timestamp":1787021069211,"version":"build-2736575974"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T00:00:00Z","timestamp":1740009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T00:00:00Z","timestamp":1740009600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["FDN154311"],"award-info":[{"award-number":["FDN154311"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["j intensive care"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Lipoproteins and their component apolipoproteins play an important role in sepsis. However, little is known with regard to the association and causal contribution of these proteins to mortality in patients of different ancestries following septic shock. The objective of this study was to determine whether lipoprotein and apolipoprotein levels, and related genetic variants, are associated with clinical outcomes in septic shock.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We investigated the association between lipoprotein and apolipoprotein levels at the point of admission to the intensive care unit and in-hospital mortality in 687 Japan patients diagnosed with septic shock. For each clinically significant candidate protein, we extracted haplotype tag single nucleotide polymorphisms (SNPs) of the corresponding gene and examined the association of the candidate gene variants with 28-day mortality and organ dysfunction. We tested for replication in a Caucasian septic shock cohort (Vasopressin and Septic Shock Trial, VASST, n\u2009=\u2009474). To determine whether the candidate lipoprotein causally contributed to septic shock outcome, we used a Mendelian randomization analysis based on polygenic scores generated from a genome-wide association study (GWAS) in the Japan cohort.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      In the Japan cohort, low apolipoprotein A-II levels were associated with increased septic shock mortality (adjusted odds ratio, 1.05; 95%CI, 1.02\u20131.09;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.001). For a haplotype tag SNP of the corresponding\n                      <jats:italic>ApoA2<\/jats:italic>\n                      gene, rs6413453 GG carriers had significantly higher 28-day mortality (adjusted hazard ratio [aHR], 1.79; 95% confidence interval [CI], 1.06\u20133.04;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.029) and significantly fewer days free of cardiovascular, respiratory, renal and neurologic dysfunction than AG\/AA carriers. This result was replicated in the Caucasian septic shock cohort (28-day mortality: aHR, 1.65; 95% CI, 1.02\u20132.68;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.041). Mendelian randomization using 9 SNPs from an apolipoprotein A-II GWAS suggested that genetically decreased levels of apolipoprotein A-II were a causal factor for increased mortality in septic shock (odds ratio for mortality due to a 1\u00a0mg\/dL decrease in apolipoprotein A-II is 1.05 [95% CI; 1.01\u20131.03,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.0022]).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      In septic shock, apolipoprotein A-II levels and\n                      <jats:italic>ApoA2<\/jats:italic>\n                      genetic variations are important factors associated with outcome.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s40560-025-00782-2","type":"journal-article","created":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T23:36:51Z","timestamp":1740008211000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Low apolipoprotein A-II levels causally contribute to increased mortality in septic shock"],"prefix":"10.1186","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9417-2396","authenticated-orcid":false,"given":"Nozomi","family":"Takahashi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyle R.","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadanaga","family":"Shimada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taka-aki","family":"Nakada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James A.","family":"Russell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith R.","family":"Walley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,20]]},"reference":[{"issue":"8","key":"782_CR1","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1001\/jama.2016.0287","volume":"315","author":"M Singer","year":"2016","unstructured":"Singer M, Deutschman CS, Seymour CW, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. 2016;315(8):801\u201310. https:\/\/doi.org\/10.1001\/jama.2016.0287.","journal-title":"JAMA"},{"key":"782_CR2","doi-asserted-by":"publisher","first-page":"i1585","DOI":"10.1136\/bmj.i1585","volume":"353","author":"JE Gotts","year":"2016","unstructured":"Gotts JE, Matthay MA. Sepsis: pathophysiology and clinical management. BMJ. 2016;353:i1585. https:\/\/doi.org\/10.1136\/bmj.i1585.","journal-title":"BMJ"},{"issue":"8","key":"782_CR3","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.1007\/s00134-020-06106-2","volume":"46","author":"R Markwart","year":"2020","unstructured":"Markwart R, Saito H, Harder T, et al. Epidemiology and burden of sepsis acquired in hospitals and intensive care units: a systematic review and meta-analysis. Intensive Care Med. 2020;46(8):1536\u201351. https:\/\/doi.org\/10.1007\/s00134-020-06106-2.","journal-title":"Intensive Care Med"},{"issue":"1","key":"782_CR4","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s00134-006-0432-y","volume":"33","author":"O Murch","year":"2007","unstructured":"Murch O, Collin M, Hinds CJ, Thiemermann C. Lipoproteins in inflammation and sepsis. I. Basic science. Intensive Care Med. 2007;33(1):13\u201324. https:\/\/doi.org\/10.1007\/s00134-006-0432-y.","journal-title":"Intensive Care Med"},{"issue":"6","key":"782_CR5","doi-asserted-by":"publisher","first-page":"3280","DOI":"10.1128\/IAI.71.6.3280-3284.2003","volume":"71","author":"JH Levels","year":"2003","unstructured":"Levels JH, Abraham PR, van Barreveld EP, Meijers JC, van Deventer SJ. Distribution and kinetics of lipoprotein-bound lipoteichoic acid. Infect Immun. 2003;71(6):3280\u20134. https:\/\/doi.org\/10.1128\/IAI.71.6.3280-3284.2003.","journal-title":"Infect Immun"},{"issue":"4","key":"782_CR6","doi-asserted-by":"publisher","first-page":"2321","DOI":"10.1128\/IAI.73.4.2321-2326.2005","volume":"73","author":"JH Levels","year":"2005","unstructured":"Levels JH, Marquart JA, Abraham PR, et al. Lipopolysaccharide is transferred from high-density to low-density lipoproteins by lipopolysaccharide-binding protein and phospholipid transfer protein. Infect Immun. 2005;73(4):2321\u20136. https:\/\/doi.org\/10.1128\/IAI.73.4.2321-2326.2005.","journal-title":"Infect Immun"},{"issue":"4","key":"782_CR7","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.4049\/jimmunol.1100253","volume":"187","author":"MB Fessler","year":"2011","unstructured":"Fessler MB, Parks JS. Intracellular lipid flux and membrane microdomains as organizing principles in inflammatory cell signaling. J Immunol. 2011;187(4):1529\u201335. https:\/\/doi.org\/10.4049\/jimmunol.1100253.","journal-title":"J Immunol"},{"issue":"19","key":"782_CR8","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1161\/CIRCULATIONAHA.110.961193","volume":"122","author":"M Suzuki","year":"2010","unstructured":"Suzuki M, Pritchard DK, Becker L, et al. High-density lipoprotein suppresses the type I interferon response, a family of potent antiviral immunoregulators, in macrophages challenged with lipopolysaccharide. Circulation. 2010;122(19):1919\u201327. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.110.961193.","journal-title":"Circulation"},{"issue":"8","key":"782_CR9","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.3390\/jcm10081693","volume":"10","author":"G Barker","year":"2021","unstructured":"Barker G, Leeuwenburgh C, Brusko T, Moldawer L, Reddy ST, Guirgis FW. Lipid and lipoprotein dysregulation in sepsis: clinical and mechanistic insights into chronic critical illness. J Clin Med. 2021;10(8):1693. https:\/\/doi.org\/10.3390\/jcm10081693.","journal-title":"J Clin Med"},{"issue":"1","key":"782_CR10","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1186\/s13054-020-02860-3","volume":"24","author":"S Tanaka","year":"2020","unstructured":"Tanaka S, Couret D, Tran-Dinh A, et al. High-density lipoproteins during sepsis: from bench to bedside. Crit Care. 2020;24(1):134. https:\/\/doi.org\/10.1186\/s13054-020-02860-3.","journal-title":"Crit Care"},{"issue":"9","key":"782_CR11","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1161\/CIRCULATIONAHA.120.048568","volume":"143","author":"M Trinder","year":"2021","unstructured":"Trinder M, Wang Y, Madsen CM, et al. Inhibition of cholesteryl ester transfer protein preserves high-density lipoprotein cholesterol and improves survival in sepsis. Circulation. 2021;143(9):921\u201334. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.120.048568.","journal-title":"Circulation"},{"issue":"7","key":"782_CR12","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1164\/rccm.201806-1157OC","volume":"199","author":"M Trinder","year":"2019","unstructured":"Trinder M, Genga KR, Kong HJ, et al. Cholesteryl ester transfer protein influences high-density lipoprotein levels and survival in sepsis. Am J Respir Crit Care Med. 2019;199(7):854\u201362. https:\/\/doi.org\/10.1164\/rccm.201806-1157OC.","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"782_CR13","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1161\/ATVBAHA.119.313381","volume":"40","author":"M Trinder","year":"2020","unstructured":"Trinder M, Walley KR, Boyd JH, Brunham LR. Causal inference for genetically determined levels of high-density lipoprotein cholesterol and risk of infectious disease. Arterioscler Thromb Vasc Biol. 2020;40(1):267\u201378. https:\/\/doi.org\/10.1161\/ATVBAHA.119.313381.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"9868","key":"782_CR14","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1016\/S0140-6736(12)61815-7","volume":"381","author":"JL Vincent","year":"2013","unstructured":"Vincent JL, Opal SM, Marshall JC, Tracey KJ. Sepsis definitions: time for change. Lancet. 2013;381(9868):774\u20135. https:\/\/doi.org\/10.1016\/S0140-6736(12)61815-7.","journal-title":"Lancet"},{"issue":"9","key":"782_CR15","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1056\/NEJMoa067373","volume":"358","author":"JA Russell","year":"2008","unstructured":"Russell JA, Walley KR, Singer J, et al. Vasopressin versus norepinephrine infusion in patients with septic shock. N Engl J Med. 2008;358(9):877\u201387. https:\/\/doi.org\/10.1056\/NEJMoa067373.","journal-title":"N Engl J Med"},{"issue":"6","key":"782_CR16","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1530\/eje.0.1420677","volume":"142","author":"J Liu","year":"2000","unstructured":"Liu J, Heikkil\u00e4 P, Meng QH, Kahri AI, Tikkanen MJ, Voutilainen R. Expression of low and high density lipoprotein receptor genes in human adrenals. Eur J Endocrinol. 2000;142(6):677\u201382. https:\/\/doi.org\/10.1530\/eje.0.1420677.","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"782_CR17","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1378\/chest.112.1.164","volume":"112","author":"GR Bernard","year":"1997","unstructured":"Bernard GR, Wheeler AP, Arons MM, et al. A trial of antioxidants N-acetylcysteine and procysteine in ARDS. The Antioxidant in ARDS Study Group. Chest. 1997;112(1):164\u201372. https:\/\/doi.org\/10.1378\/chest.112.1.164.","journal-title":"Chest"},{"issue":"11","key":"782_CR18","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1007\/s00134-022-06778-y","volume":"48","author":"JA Russell","year":"2022","unstructured":"Russell JA, Meyer NJ, Walley KR. Use of Mendelian randomization to better understand and treat sepsis. Intensive Care Med. 2022;48(11):1638\u201341. https:\/\/doi.org\/10.1007\/s00134-022-06778-y.","journal-title":"Intensive Care Med"},{"issue":"7982","key":"782_CR19","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/s41586-023-06592-6","volume":"622","author":"BB Sun","year":"2023","unstructured":"Sun BB, Chiou J, Traylor M, et al. Plasma proteomic associations with genetics and health in the UK Biobank. Nature. 2023;622(7982):329\u201338. https:\/\/doi.org\/10.1038\/s41586-023-06592-6.","journal-title":"Nature"},{"issue":"5\u20136","key":"782_CR20","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.humimm.2017.03.010","volume":"78","author":"F Venet","year":"2017","unstructured":"Venet F, Schilling J, Cazalis MA, et al. Modulation of LILRB2 protein and mRNA expressions in septic shock patients and after ex vivo lipopolysaccharide stimulation. Hum Immunol. 2017;78(5\u20136):441\u201350. https:\/\/doi.org\/10.1016\/j.humimm.2017.03.010.","journal-title":"Hum Immunol"},{"issue":"9","key":"782_CR21","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1038\/s41588-021-00913-z","volume":"53","author":"U V\u00f5sa","year":"2021","unstructured":"V\u00f5sa U, Claringbould A, Westra HJ, et al. Large-scale cis- and trans-eQTL analyses identify thousands of genetic loci and polygenic scores that regulate blood gene expression. Nat Genet. 2021;53(9):1300\u201310. https:\/\/doi.org\/10.1038\/s41588-021-00913-z.","journal-title":"Nat Genet"},{"issue":"5","key":"782_CR22","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/ng.3538","volume":"48","author":"Z Zhu","year":"2016","unstructured":"Zhu Z, Zhang F, Hu H, et al. Integration of summary data from GWAS and eQTL studies predicts complex trait gene targets. Nat Genet. 2016;48(5):481\u20137. https:\/\/doi.org\/10.1038\/ng.3538.","journal-title":"Nat Genet"},{"key":"782_CR23","doi-asserted-by":"publisher","first-page":"n2233","DOI":"10.1136\/bmj.n2233","volume":"375","author":"VW Skrivankova","year":"2021","unstructured":"Skrivankova VW, Richmond RC, Woolf BAR, et al. Strengthening the reporting of observational studies in epidemiology using Mendelian randomisation (STROBE-MR): explanation and elaboration. BMJ. 2021;375:n2233. https:\/\/doi.org\/10.1136\/bmj.n2233.","journal-title":"BMJ"},{"issue":"2","key":"782_CR24","doi-asserted-by":"publisher","first-page":"H866","DOI":"10.1152\/ajpheart.01232.2008","volume":"297","author":"Z Zhang","year":"2009","unstructured":"Zhang Z, Datta G, Zhang Y, et al. Apolipoprotein A-I mimetic peptide treatment inhibits inflammatory responses and improves survival in septic rats. Am J Physiol Heart Circ Physiol. 2009;297(2):H866\u201373. https:\/\/doi.org\/10.1152\/ajpheart.01232.2008.","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"2","key":"782_CR25","doi-asserted-by":"publisher","first-page":"R60","DOI":"10.1186\/cc11305","volume":"16","author":"SB Kumaraswamy","year":"2012","unstructured":"Kumaraswamy SB, Linder A, \u00c5kesson P, Dahlb\u00e4ck B. Decreased plasma concentrations of apolipoprotein M in sepsis and systemic inflammatory response syndromes. Crit Care. 2012;16(2):R60. https:\/\/doi.org\/10.1186\/cc11305.","journal-title":"Crit Care"},{"issue":"5","key":"782_CR26","doi-asserted-by":"publisher","first-page":"e64486","DOI":"10.1371\/journal.pone.0064486","volume":"8","author":"OF Sharifov","year":"2013","unstructured":"Sharifov OF, Xu X, Gaggar A, et al. Anti-inflammatory mechanisms of apolipoprotein A-I mimetic peptide in acute respiratory distress syndrome secondary to sepsis. PLoS ONE. 2013;8(5):e64486. https:\/\/doi.org\/10.1371\/journal.pone.0064486.","journal-title":"PLoS ONE"},{"issue":"1","key":"782_CR27","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s13613-017-0284-3","volume":"7","author":"S Tanaka","year":"2017","unstructured":"Tanaka S, Labreuche J, Drumez E, et al. Low HDL levels in sepsis versus trauma patients in intensive care unit. Ann Intensive Care. 2017;7(1):60. https:\/\/doi.org\/10.1186\/s13613-017-0284-3.","journal-title":"Ann Intensive Care"},{"key":"782_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.jlr.2021.100099","volume":"62","author":"JT Melchior","year":"2021","unstructured":"Melchior JT, Street SE, Vaisar T, et al. Apolipoprotein A-I modulates HDL particle size in the absence of apolipoprotein A-II. J Lipid Res. 2021;62: 100099. https:\/\/doi.org\/10.1016\/j.jlr.2021.100099.","journal-title":"J Lipid Res"},{"issue":"3","key":"782_CR29","doi-asserted-by":"publisher","first-page":"44","DOI":"10.3390\/biomedicines8030044","volume":"8","author":"H Boughanem","year":"2020","unstructured":"Boughanem H, Bandera-Merch\u00e1n B, Hern\u00e1ndez-Alonso P, et al. Association between the\u00a0APOA2\u00a0rs3813627 single nucleotide polymorphism and HDL and APOA1 levels through BMI. Biomedicines. 2020;8(3):44. https:\/\/doi.org\/10.3390\/biomedicines8030044.","journal-title":"Biomedicines."},{"issue":"8","key":"782_CR30","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1097\/01.ccm.0000171183.79525.6b","volume":"33","author":"JY Chien","year":"2005","unstructured":"Chien JY, Jerng JS, Yu CJ, Yang PC. Low serum level of high-density lipoprotein cholesterol is a poor prognostic factor for severe sepsis. Crit Care Med. 2005;33(8):1688\u201393. https:\/\/doi.org\/10.1097\/01.ccm.0000171183.79525.6b.","journal-title":"Crit Care Med"},{"issue":"11","key":"782_CR31","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1016\/S0022-2275(20)31499-1","volume":"42","author":"F Blanco-Vaca","year":"2001","unstructured":"Blanco-Vaca F, Escol\u00e0-Gil JC, Mart\u00edn-Campos JM, Julve J. Role of apoA-II in lipid metabolism and atherosclerosis: advances in the study of an enigmatic protein. J Lipid Res. 2001;42(11):1727\u201339.","journal-title":"J Lipid Res"},{"issue":"9","key":"782_CR32","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1007\/s11745-002-0981-4","volume":"37","author":"CJ Furlaneto","year":"2002","unstructured":"Furlaneto CJ, Ribeiro FP, Hatanaka E, Souza GM, Cassatella MA, Campa A. Apolipoproteins A-I and A-II downregulate neutrophil functions. Lipids. 2002;37(9):925\u20138. https:\/\/doi.org\/10.1007\/s11745-002-0981-4.","journal-title":"Lipids"},{"issue":"2","key":"782_CR33","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1179\/096805105X35215","volume":"11","author":"JF Berb\u00e9e","year":"2005","unstructured":"Berb\u00e9e JF, Havekes LM, Rensen PC. Apolipoproteins modulate the inflammatory response to lipopolysaccharide. J Endotoxin Res. 2005;11(2):97\u2013103. https:\/\/doi.org\/10.1179\/096805105X35215.","journal-title":"J Endotoxin Res"},{"issue":"6","key":"782_CR34","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1177\/1753425908099171","volume":"14","author":"PA Thompson","year":"2008","unstructured":"Thompson PA, Berb\u00e9e JF, Rensen PC, Kitchens RL. Apolipoprotein A-II augments monocyte responses to LPS by suppressing the inhibitory activity of LPS-binding protein. Innate Immun. 2008;14(6):365\u201374. https:\/\/doi.org\/10.1177\/1753425908099171.","journal-title":"Innate Immun"},{"issue":"3","key":"782_CR35","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1111\/cts.13462","volume":"16","author":"G Liu","year":"2023","unstructured":"Liu G, Jiang L, Kerchberger VE, et al. The relationship between high density lipoprotein cholesterol and sepsis: a clinical and genetic approach. Clin Transl Sci. 2023;16(3):489\u2013501. https:\/\/doi.org\/10.1111\/cts.13462.","journal-title":"Clin Transl Sci"},{"key":"782_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2024.104981","volume":"100","author":"R Taylor","year":"2024","unstructured":"Taylor R, Zhang C, George D, et al. Low circulatory levels of total cholesterol, HDL-C and LDL-C are associated with death of patients with sepsis and critical illness: systematic review, meta-analysis, and perspective of observational studies. EBioMedicine. 2024;100: 104981. https:\/\/doi.org\/10.1016\/j.ebiom.2024.104981.","journal-title":"EBioMedicine"},{"issue":"7","key":"782_CR37","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1038\/labinvest.2016.56","volume":"96","author":"DA Chistiakov","year":"2016","unstructured":"Chistiakov DA, Orekhov AN, Bobryshev YV. ApoA1 and ApoA1-specific self-antibodies in cardiovascular disease. Lab Invest. 2016;96(7):708\u201318. https:\/\/doi.org\/10.1038\/labinvest.2016.56.","journal-title":"Lab Invest"},{"issue":"15","key":"782_CR38","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1161\/CIRCULATIONAHA.113.002624","volume":"128","author":"JA DiDonato","year":"2013","unstructured":"DiDonato JA, Huang Y, Aulak KS, et al. Function and distribution of apolipoprotein A1 in the artery wall are markedly distinct from those in plasma. Circulation. 2013;128(15):1644\u201355. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.113.002624.","journal-title":"Circulation"},{"issue":"3","key":"782_CR39","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1007\/BF00366253","volume":"79","author":"HR Middleton-Price","year":"1988","unstructured":"Middleton-Price HR, van den Berghe JA, Scott J, Knott TJ, Malcolm S. Regional chromosomal localisation of APOA2 to 1q21-1q23. Hum Genet. 1988;79(3):283\u20135. https:\/\/doi.org\/10.1007\/BF00366253.","journal-title":"Hum Genet"},{"issue":"Pt 2","key":"782_CR40","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1111\/j.1469-1809.2007.00416.x","volume":"72","author":"SJ Hasstedt","year":"2008","unstructured":"Hasstedt SJ, Chu WS, Das SK, Wang H, Elbein SC. Type 2 diabetes susceptibility genes on chromosome 1q21-24. Ann Hum Genet. 2008;72(Pt 2):163\u20139. https:\/\/doi.org\/10.1111\/j.1469-1809.2007.00416.x.","journal-title":"Ann Hum Genet"},{"key":"782_CR41","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1471-2350-10-13","volume":"10","author":"K Duesing","year":"2009","unstructured":"Duesing K, Charpentier G, Marre M, et al. Evaluating the association of common APOA2 variants with type 2 diabetes. BMC Med Genet. 2009;10:13. https:\/\/doi.org\/10.1186\/1471-2350-10-13.","journal-title":"BMC Med Genet"},{"issue":"9","key":"782_CR42","doi-asserted-by":"publisher","first-page":"e1005506","DOI":"10.1371\/journal.pgen.1005506","volume":"11","author":"O Kluth","year":"2015","unstructured":"Kluth O, Matzke D, Kamitz A, et al. Identification of four mouse diabetes candidate genes altering \u03b2-cell proliferation. PLoS Genet. 2015;11(9):e1005506. https:\/\/doi.org\/10.1371\/journal.pgen.1005506.","journal-title":"PLoS Genet"},{"issue":"1","key":"782_CR43","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1038\/ng.3737","volume":"49","author":"DV Zhernakova","year":"2017","unstructured":"Zhernakova DV, Deelen P, Vermaat M, et al. Identification of context-dependent expression quantitative trait loci in whole blood. Nat Genet. 2017;49(1):139\u201345. https:\/\/doi.org\/10.1038\/ng.3737.","journal-title":"Nat Genet"},{"issue":"12","key":"782_CR44","doi-asserted-by":"publisher","first-page":"6720","DOI":"10.1074\/jbc.271.12.6720","volume":"271","author":"A Marzal-Casacuberta","year":"1996","unstructured":"Marzal-Casacuberta A, Blanco-Vaca F, Ishida BY, et al. Functional lecithin:cholesterol acyltransferase deficiency and high density lipoprotein deficiency in transgenic mice overexpressing human apolipoprotein A-II. J Biol Chem. 1996;271(12):6720\u20138. https:\/\/doi.org\/10.1074\/jbc.271.12.6720.","journal-title":"J Biol Chem"},{"issue":"30","key":"782_CR45","doi-asserted-by":"publisher","first-page":"21630","DOI":"10.1016\/S0021-9258(19)36658-X","volume":"267","author":"JR Schultz","year":"1992","unstructured":"Schultz JR, Gong EL, McCall MR, Nichols AV, Clift SM, Rubin EM. Expression of human apolipoprotein A-II and its effect on high density lipoproteins in transgenic mice. J Biol Chem. 1992;267(30):21630\u20136.","journal-title":"J Biol Chem"},{"issue":"27","key":"782_CR46","doi-asserted-by":"publisher","first-page":"20676","DOI":"10.1016\/S0021-9258(20)80777-7","volume":"268","author":"CC Hedrick","year":"1993","unstructured":"Hedrick CC, Castellani LW, Warden CH, Puppione DL, Lusis AJ. Influence of mouse apolipoprotein A-II on plasma lipoproteins in transgenic mice. J Biol Chem. 1993;268(27):20676\u201382.","journal-title":"J Biol Chem"}],"container-title":["Journal of Intensive Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40560-025-00782-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40560-025-00782-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40560-025-00782-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T23:36:59Z","timestamp":1740008219000},"score":1,"resource":{"primary":{"URL":"https:\/\/jintensivecare.biomedcentral.com\/articles\/10.1186\/s40560-025-00782-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,20]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["782"],"URL":"https:\/\/doi.org\/10.1186\/s40560-025-00782-2","relation":{},"ISSN":["2052-0492"],"issn-type":[{"value":"2052-0492","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,20]]},"assertion":[{"value":"12 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Institutional Review Board of Chiba University Graduate School of Medicine, and the Institutional Review Board of St. Paul\u2019s Hospital and the University of British Columbia. The requirement to obtain written informed consent was waived because of the study design.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"10"}}